In addition, monoclonal antibodies, which are produced by patients with acquired TTP and recognize the TSP8 domain, increase the enzymatic cleavage activity of ADAMTS13 by ~2-fold [8]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.